2024

1. Cong J*, Liu P*, Han Z*, Ying W, Li C, Yang J, Song X, Dai L, Sun L, Kasper D, Pan W#, Zhu S#. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions. Immunity. 2024 Mar 6:S1074-7613(24)00090-6. doi: 10.1016/j.immuni.2024.02.014. (IF=43.5)

Preview in: Immunity.doi: 10.1016/j.immuni.2024.03.006. Hostile bile limits anti-cancer immunity.

 

2. Li C, Zhang P, Xie Y, Wang S, Guo M, Wei X, Zhang K, Cao D, Zhou R, Wang S, Song X#, Zhu S#, Pan W#.  Enterococcus-derived tyramine hijacks α2A-adrenergic receptor in intestinal stem cells to exacerbate colitis. Cell Host Microbe. 2024 May 21:S1931-3128(24)00140-9. doi: 10.1016/j.chom.2024.04.020. (IF=30.1)

 

3. Zhu S#, Pan W#. Microbial metabolite steers intestinal stem cell fate under stress. Cell Stem Cell. doi.org/10.1016/j.stem.2024.04.006. (IF=23.9)

 

4. Ren X, Liu Q, Zhou P, Zhou T, Wang D, Mei Q, Flavell RA, Liu Z#, Li M#, Pan W#, Zhu S#. DHX9 maintains epithelial homeostasis by restraining R-loop-mediated genomic instability in intestinal stem cells. Nature Communications. 2024 Apr 9;15(1):3080. doi: 10.1038/s41467-024-47235-2. (IF=16.6)

 

5. Hu J*, He K*, Yang Y*, Huang C, Dou Y, Wang H, Zhang G, Wang J, Niu C, Bi G, Zhang L#, Zhu S#. Amino acid formula induces microbiota dysbiosis and depressive-like behavior in mice. Cell Reports. 2024 Feb 26;43(3):113817. doi: 10.1016/j.celrep.2024.113817. (IF=10.0)

 

6. Li R*, Zan Y*, Wang D, Chen X, Wang A, Tan H, Zhang G, Ding S, Shen C#, Wu H#, Zhu S#. A mouse model to distinguish NLRP6-mediated inflammasome-dependent and -independent functionsPNAS. 2024 Feb 6;121(6):e2321419121. doi: 10.1073/pnas.2321419121. (IF=11.1)

 

7. W Cui, M Guo, D Liu, Y Zhang, J Cong, Z Han, Y Yang, J Liu, C Liang, S Shi, P Xiao, C Yang, H Huang, X Fu, Y Xu, L Du, C Yin, Y Zhang, J Sun, R Chai#, W Gu#, S Zhu#, B Chu#. Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nature Cell Biology. 26, 124–137 (2024). (IF=28.2)